CoreWeave Inc. CRWV
87.59
(2.54)
(2.82%)
as of 25 Sep
- Market cap
- $50.5B
- P/E
- 0.0×
Follow CRWV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+7 more quarters Free account |
P/S ratio |
7.23 | 6.56 | 6.07 | 15.82 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
80.78 | 13.68 | 19.98 | 40.34 | |
P/B ratio |
10.92 | 8.58 | 9.34 | 17.57 | |
Price to Tangible BV |
14.91 | 11.89 | 15.58 | 23.92 | |
EV/Sales |
11.03 | 10.09 | 9.50 | 18.49 | |
EV/EBITDA |
21.53 | 20.22 | 19.36 | 35.35 | |
EV/Operating CF |
12.11 | 10.51 | 15.94 | 47.24 | |
EV/FCF |
(6.13) | (5.92) | (6.72) | (9.88) | |
Quick Ratio |
0.43 | 0.29 | 0.43 | 0.43 | |
Current Ratio |
0.46 | 0.31 | 0.46 | 0.49 | |
Net Debt/EBITDA |
20.78 | 21.10 | 23.39 | 16.35 | |
Debt/Assets |
45.78% | 45.12% | 43.79% | 42.65% | |
Debt/Equity |
7.02 | 5.27 | 6.47 | 3.62 | |
Asset Turnover |
0.15 | 0.16 | 0.15 | 0.26 | |
Operating CF/Net income |
(1.08) | (4.03) | (3.44) | (15.34) | |
Capex/Depreciation |
(4.47) | (6.48) | (4.82) | (3.67) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.24% | 11.21% | 12.88% | 14.40% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
6.41% | 7.36% | 9.96% | 10.58% | |
Graham Net Nets |
(1.14) | (1.11) | (1.24) | (0.36) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.67%) | (4.01%) | (4.34%) | (1.71%) | |
Free Cash Flow Yield |
(24.90%) | (26.00%) | (23.28%) | (11.83%) | |
Revenue per Share |
4.67 | 3.94 | 3.61 | 2.74 | |
Operating CF per Share |
1.23 | 5.66 | 3.58 | 3.39 | |
Capex per Share |
(11.66) | (14.60) | (9.33) | (4.80) | |
Free Cash Flow per Share |
(10.42) | (8.94) | (5.75) | (1.41) | |
Cash per Share |
11.64 | 5.77 | 9.15 | 5.10 | |
Shareholders Equity per Share |
9.12 | 9.03 | 7.67 | 7.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.12 | 9.03 | 7.67 | 7.79 | |
Free Cash Flow |
(5,743.00) | (4,711.00) | (2,500.81) | (700.19) | |
Working Capital |
(11,397.00) | (12,209.00) | (8,952.00) | (4,983.59) | |
Capital Expenditures |
(6,422.00) | (7,695.00) | (4,059.76) | (2,389.24) | |
Net Current Asset Value |
(62,526.00) | (45,205.00) | (38,479.00) | (24,301.20) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 509.92 | |
Capex to Sales |
2.49 | 3.70 | 2.58 | 1.75 | |
Net Profit Margin |
(24.31%) | (35.61%) | (28.80%) | (8.07%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 436.30 | |
| Other line items | |||||
Average Receivables |
2,237.35 | 1,587.60 | 1,793.00 | — | |
Average Payables |
2,429.79 | 2,306.55 | 1,245.50 | — | |
Average Assets |
51,655.68 | 38,716.69 | 33,567.50 | 16,455.25 | |
Average Common Equity |
3,840.82 | 3,332.56 | 1,460.50 | — |
Columns are period end dates